Shanghai-based Qiao Peng  at R&P China Lawyers is a former global compliance director at  pharmaceutical and biotechnology giant AstraZeneca; Peng’s compliance practice covers advice to multinationals on commercial bribery, The Foreign Corrupt Practices Act, data privacy and fraud, along with internal control systems and compliance investigations.

Legal 500 Editorial commentary